Influence of PPAR-gama receptor agonists on antitumor activity of photodynamic therapy.
2012/05/N/NZ5/02616
Keywords
Descriptors
- NZ5_7: Leczenie chorób człowieka
- NZ5_9: Inne zagadnienia pokrewne
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Warszawski Uniwersytet Medyczny, Wydział Nauki o Zdrowiu
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 3 – announced on 2012-03-15
- Amount awarded
- 98 020 PLN
- Project start date
- 2013-03-12
- Project end date
- 2015-03-11
- Project duration
- 24 months (the same as in the proposal)
- Project status
- Project settled
Information in the final report
Publication in academic press/journals (1)
-
PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells.
- Authors:
- E Glodkowska-Mrowka, A Manda-Handzlik, A Stelmaszczyk-Emmel, I Seferynska,3 T Stoklosa,J Przybylski, P Mrowka
- Academic press:
- Blood Cancer Journal (year: 2016, volume: 6, pages: e377), Publisher: Nature Publishing Group
- Status:
- Published
- DOI:
- 10.1038/bcj.2015.109 – link to the publication